These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3525416)

  • 1. Composition of affinity-purified alpha-hemolysin of Escherichia coli.
    Bohach GA; Snyder IS
    Infect Immun; 1986 Aug; 53(2):435-7. PubMed ID: 3525416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical and immunological analysis of the complex structure of Escherichia coli alpha-hemolysin.
    Bohach GA; Snyder IS
    J Bacteriol; 1985 Dec; 164(3):1071-80. PubMed ID: 3905764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitopes of Escherichia coli alpha-hemolysin: identification of monoclonal antibodies that prevent hemolysis.
    Ji GE; O'Hanley P
    Infect Immun; 1990 Sep; 58(9):3029-35. PubMed ID: 1696938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of Escherichia coli alpha-hemolysin.
    Bohach GA; Cavalieri SJ; Snyder IS
    Methods Enzymol; 1988; 165():137-46, 399. PubMed ID: 3068483
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune response to Escherichia coli alpha-hemolysin in patients.
    Seetharama S; Cavalieri SJ; Snyder IS
    J Clin Microbiol; 1988 May; 26(5):850-6. PubMed ID: 2454938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary Escherichia coli infection presenting with jaundice.
    Emody L; Molnár L; Kellermayer M; Paál M; Wadström T
    Scand J Infect Dis; 1989; 21(5):579-82. PubMed ID: 2685987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restriction fragment length polymorphisms associated with alpha-hemolysin determinants are correlating with the expression of alpha-hemolysin in strains of Escherichia coli.
    Prada J; Zimmermann S; Stephan R; Beutin L
    Zentralbl Bakteriol; 1992 Jan; 276(2):152-64. PubMed ID: 1348436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial characterisation of Escherichia coli haemolysin.
    Rennie RP; Arbuthnott JP
    J Med Microbiol; 1974 May; 7(2):179-88. PubMed ID: 4209269
    [No Abstract]   [Full Text] [Related]  

  • 9. Purification of alpha-hemolysin from an overproducing E. coli strain.
    Gonzalez-Carreró MI; Zabala JC; de la Cruz F; Ortiz JM
    Mol Gen Genet; 1985; 199(1):106-10. PubMed ID: 3889545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic conservation of hlyA determinants and serological conservation of HlyA: basis for developing a broadly cross-reactive subunit Escherichia coli alpha-hemolysin vaccine.
    O'Hanley P; Marcus R; Baek KH; Denich K; Ji GE
    Infect Immun; 1993 Mar; 61(3):1091-7. PubMed ID: 8432591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domains of Escherichia coli hemolysin (HlyA) involved in binding of calcium and erythrocyte membranes.
    Boehm DF; Welch RA; Snyder IS
    Infect Immun; 1990 Jun; 58(6):1959-64. PubMed ID: 2187815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-haemolysin from E. coli. Purification and self-aggregation properties.
    Ostolaza H; Bartolomé B; Serra JL; de la Cruz F; Goñi FM
    FEBS Lett; 1991 Mar; 280(2):195-8. PubMed ID: 2013312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of monoclonal antibodies against the Escherichia coli hemolysin.
    Pellett S; Boehm DF; Snyder IS; Rowe G; Welch RA
    Infect Immun; 1990 Mar; 58(3):822-7. PubMed ID: 1689701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropic effects of a mutation in rfaC on Escherichia coli hemolysin.
    Bauer ME; Welch RA
    Infect Immun; 1997 Jun; 65(6):2218-24. PubMed ID: 9169754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of monoclonal antibodies against alpha-hemolysin of Escherichia coli.
    Oropeza-Wekerle RL; Kern P; Sun D; Muller S; Briand JP; Goebel W
    Infect Immun; 1991 May; 59(5):1846-52. PubMed ID: 1708360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient production of endotoxin depleted bioactive α-hemolysin of uropathogenic
    Verma V; Gupta S; Kumar P; Rawat A; Singh Dhanda R; Yadav M
    Prep Biochem Biotechnol; 2019; 49(6):616-622. PubMed ID: 30929584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of antibodies to functional epitopes on the pore formed by Escherichia coli hemolysin in cells and model membranes.
    Menestrina G; Ropele M; Dalla Serra M; Pederzolli C; Hugo F; Pellet S; Welch RA
    Biochim Biophys Acta; 1995 Aug; 1238(1):72-80. PubMed ID: 7654753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial purification of alpha-hemolysin in Escherichia coli.
    Nistiar F; Janigová V; Durovicová J; Puzová H
    Folia Microbiol (Praha); 1991; 36(4):395-400. PubMed ID: 1822842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escherichia coli alpha-hemolysin: characteristics and probable role in pathogenicity.
    Cavalieri SJ; Bohach GA; Snyder IS
    Microbiol Rev; 1984 Dec; 48(4):326-43. PubMed ID: 6394977
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemolysins and verotoxin (VT) in enteric Escherichia coli isolated from pigs.
    Zamora J; Reinhardt G; Polette M; Macías P
    Rev Latinoam Microbiol; 1997; 39(3-4):159-65. PubMed ID: 10932726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.